MYOADENYLATE DEAMINASE DEFICIENCY - FUNCTIONAL AND METABOLIC ABNORMALITIES ASSOCIATED WITH DISRUPTION OF THE PURINE NUCLEOTIDE CYCLE
MYOADENYLATE DEAMINASE DEFICIENCY - FUNCTIONAL AND METABOLIC ABNORMALITIES ASSOCIATED WITH DISRUPTION OF THE PURINE NUCLEOTIDE CYCLE
复制标题
DOI:
10.1172/jci111265
复制
发表时间:
1984-01-01
影响因子:
15.9
通讯作者:
HOLMES, EW
中科院分区:
文献类型:
--
作者:
SABINA, RL;SWAIN, JL;HOLMES, EW
To assess the role of the purine nucleotide cycle in human skeletal muscle function, 10 patients with AMP deaminase deficiency (myoadenylate deaminase deficiency; MDD) were studied. MDD (4) and non-MDD (19) controls participated in an exercise protocol. The latter group was composed of a patient cohort (n = 8) exhibiting a constellation of symptoms similar to those of the MDD patients, i.e., postexertional aches, cramps and pains; as well as a cohort of normal, unconditioned volunteers (n = 11). The indivudals with MDD fatigued after performing only 28% as much work as their non-MDD counterparts. Results demonstrate that AMP deaminase deficiency leads to reduced entry of adenine nucleotides into the purine nucleotide cycle during exercise. The resultant disruption of the purine nucleotide evidently accounts for the muscle dysfunction observed in these patients.